Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty
Launched by VIVOZON, INC. · Jun 20, 2019
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women between 18-70 years old, inclusive. Female subjects must meet additional criteria according to childbearing potential.
- • Planning to undergo abdominoplasty
- • Ability to provide written informed consent
- • Ability to understand study procedures and communicate clearly with the investigator and staff
- • American Society of Anesthesiologists (ASA) risk class of I to II.
- Exclusion Criteria:
- • Emergency or unplanned surgery
- • Previous abdominoplasty
- • Pre-existing condition causing preoperative pain around the site of surgery
- • Women who are pregnant or breastfeeding
- • Chronic pain diagnosis and ongoing or frequent use of pain medications
About Vivozon, Inc.
Vivozon, Inc. is a biopharmaceutical company dedicated to advancing innovative therapies for the treatment of complex diseases. With a strong emphasis on research and development, Vivozon focuses on leveraging cutting-edge science and technology to address unmet medical needs. The company is committed to conducting rigorous clinical trials that ensure the safety and efficacy of its product candidates, fostering collaboration with healthcare professionals, regulatory bodies, and the scientific community. Vivozon aims to improve patient outcomes and enhance quality of life through its pioneering therapeutic solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Antonio, Texas, United States
Dayton, Ohio, United States
Anaheim, California, United States
Phoenix, Arizona, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Doo Lee, PhD
Study Chair
Vivozon, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials